FAERS + CAERS • Kratom (Mitragynine)

One page for parents and policymakers: what each FDA dataset is, how to open it yourself, and the headline counts for kratom (mitragynine).

Last updated: October 2025
FDA CAERS Data (Foods & Dietary Supplements)
Kratom • Mitragynine

Mitragynine (Kratom) — CAERS Snapshot

Total reports
733
Deaths
258
Hospitalizations
191
Serious cases
404
What CAERS is
CAERS is FDA CFSAN’s spontaneous adverse-event reporting system for foods and dietary supplements. Reports do not prove causation and may be incomplete or duplicative, but they help detect safety signals.
Open CAERS yourself
• FDA overview: CFSAN Adverse Event Reporting System (CAERS)
• Download data files / dashboard when available and search terms like kratom, mitragynine, Mitragyna speciosa.
• Filter by Outcome (death, hospitalization) and export to CSV/JSON for analysis.
Source: CAERS JSON (uploaded to MAHA) Scope: Kratom/Mitragynine only
FDA FAERS Data (Drugs & Biologics)
Kratom • Mitragynine

Mitragynine (Kratom) — FAERS Snapshot

Total reports
1,452
Deaths
714
Hospitalizations
362
% with death outcome
49%
What FAERS is
FAERS is the FDA’s spontaneous adverse-event reporting system for drugs/biologics. Like CAERS, it detects signals and does not by itself prove causation.
Open FAERS yourself
• Public dashboard: FAERS Public Dashboard
• In the dashboard, search for mitragynine or related terms; view counts by Outcome (death, hospitalization), and export.
Source: FAERS line listing provided to MAHA Scope: Kratom/Mitragynine only
Important context: Both FAERS and CAERS are spontaneous reporting systems. Figures reflect what was reported; they help identify signals but do not establish incidence or causation. Under- and over-reporting can occur; media attention and product labeling affect trends.
← Home ↩︎ Evidence & Data